IsoPlexis Aktie - ISO

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

0,7616

Gebot

0,8468

Fragen

0,79

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

0,7616

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company PR...

IsoPlexis Reports Preliminary Full Year 2022 Revenue

BRANFORD, Conn., Jan. 12, 2023 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (NASDAQ: ISO), a company empowering...

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth...

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company PR Newswire EMERYVILLE...

IsoPlexis Reports Third Quarter 2022 Financial Results

BRANFORD, Conn., Nov. 10, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering...

IsoPlexis to Participate in Upcoming Investor Conferences

BRANFORD, Conn., Nov. 09, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering...

IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

BRANFORD, Conn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO), a company empowering...

IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform

BRANFORD, Conn., Sept. 13, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a...

IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer Patients

BRANFORD, Conn., Sept. 06, 2022 (GLOBE NEWSWIRE) -- IsoPlexis (NASDAQ: ISO), a company empowering labs to...

IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference

BRANFORD, Conn., Aug. 31, 2022 (GLOBE NEWSWIRE) -- IsoPlexis Corporation (Nasdaq: ISO) (“IsoPlexis”), a...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

ISO - Frequently Asked Questions (FAQ)

What is the current IsoPlexis share price?

The current share price of IsoPlexis is US$ 0,7616

What is the 1 year trading range for IsoPlexis share price?

IsoPlexis has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
GATEMarblegate Acquisition Corporation	US$ 57,96 (256,46%)	77,14k
LYTLytus Technologies Holdings PTV Ltd	US$ 0,11725 (88,20%)	1,01B
DRCTDirect Digital Holdings Inc	US$ 1,33 (71,61%)	24,25M
GTECGreenland Technologies Holding Corporation	US$ 2,1701 (65,66%)	78,57M
NKTXNkarta Inc	US$ 1,975 (44,16%)	27,28M
TDTHTrident Digital Tech Holdings Ltd	US$ 0,5905 (-60,90%)	45,25M
LGMKLogicMark Inc	US$ 0,0505 (-45,29%)	54,05M
EQEquillium Inc	US$ 0,4603 (-39,27%)	1,34M
NXUNXU Inc	US$ 0,1688 (-36,28%)	10,76M
SAIHSAIHEAT Ltd	US$ 5,72 (-33,40%)	53,5k
LYTLytus Technologies Holdings PTV Ltd	US$ 0,11725 (88,20%)	1,01B
DMNDamon Inc	US$ 0,0447 (14,91%)	432,5M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10,62 (0,66%)	286,67M
NVDANVIDIA Corporation	US$ 111,43 (-2,05%)	236,84M
OCEAOcean Biomedical Inc	US$ 0,074 (-11,59%)	220,93M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

IsoPlexis Corporation (ISO)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ISO Neueste Nachrichten

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

IsoPlexis Reports Preliminary Full Year 2022 Revenue

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

IsoPlexis Reports Third Quarter 2022 Financial Results

IsoPlexis to Participate in Upcoming Investor Conferences

IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform

IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer Patients

IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference

ISO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

IsoPlexis Corporation (ISO) Börsenkurse

IsoPlexis Corporation (ISO)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

ISO Neueste Nachrichten

Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company

IsoPlexis Reports Preliminary Full Year 2022 Revenue

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company

IsoPlexis Reports Third Quarter 2022 Financial Results

IsoPlexis to Participate in Upcoming Investor Conferences

IsoPlexis to Report Third Quarter 2022 Financial Results on November 10, 2022

IsoPlexis Announces First APAC Publication, Illustrating Early Impact of Codeplex Platform

IsoPlexis Partners with MediMergent and The Center for Cancer and Blood Disorders in Study of AZD7442 for Prevention of COVID-19 Infection in Immuno-Compromised Cancer Patients

IsoPlexis to Participate in the Morgan Stanley Global Healthcare Conference

ISO - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Werbung entfernen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS